On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now

Blog


Algae Dynamics Corp. (ADYNF) Creating a Lucrative Niche Opportunity

  • Cannabis is fastest-growing industry in North America
  • Canada’s cannabis market is ripe for explosive growth
  • Algae Dynamics carving out niche in explosive market

The fastest-growing industry with the most consistent growth rate in North America is legal marijuana. A recent Forbes article says that the market could grow 700% by 2020 (http://dtn.fm/8RMvi). Investors have become acutely aware, which explains the movement in some marijuana stocks that have risen dramatically over the last 18 months.

According to ArcView, a well-known cannabis research firm, North American sales of legal medical and recreational cannabis soared 34% in 2016 to $6.9 billion. These markets are expected to continue to grow at a blistering pace of over 25 percent annually through 2021, reaching approximately $22 billion. Growth is expected to come from further jurisdictional expansion of legalization, plus rapid organic growth in areas where the drug is already legal. Mexico recently legalized medical cannabis throughout the country, and, in Canada, the number of eligible medical patients has been growing at a pace of almost 10% per month, according to Health Canada. Canada’s government has also introduced legislation to make recreational marijuana legal across the country by this time next year.

A professional consulting group hired to assess Canada’s proposed recreational marijuana market says that jurisdictions that regulate cannabis should expect “unbelievably high” sales growth in the first few years as criminals are driven out of business (http://dtn.fm/Q6ucS). Not yet authorized to discuss findings on future Canadian cannabis markets because of contracts with Health Canada, a look at the group’s estimates for Colorado’s regulated cannabis industry suggests that Canada can expect its own markets to generate billions of dollars per year in direct and indirect economic activity. While every jurisdiction is different, Canada’s population is seven times larger than that of Colorado, where regulated marijuana sales skyrocketed 42 percent between 2014 and 2015 and totaled nearly $1 billion. Numbers out of Canada could easily be seven to 10 times as much as Colorado.

Many of the better known marijuana stocks have already moved in anticipation of the forthcoming windfall of business. The way to make money on this incoming avalanche of revenues is to find and exploit a niche market, which is exactly what Algae Dynamics Corp. (OTCQB: ADYNF) is in the midst of undertaking. Algae Dynamics is focused on the extraction of oils from hemp, cannabis and algae for use in unique health products and pharmaceuticals. The company has already engaged two highly respected universities to provide research into the various uses of cannabis and hemp oil extracts, which, in combination with other compounds, may prove effective in treating cancers of the colon-rectum, pancreas, breast and prostate, as well as for the development of novel pharmacotherapies for various mental health maladies.

With medical marijuana already legal in Canada, Algae Dynamics is carving out a lucrative niche in an explosive market and is positioned to succeed. However, the legalization of recreational marijuana could propel the company far beyond what one would normally expect. One would suspect the company of being prepared with product and processes to profit from recreational legalization as well. Cannabis sales in Colorado soared 42 percent in the year recreational use was allowed. Canada’s cannabis markets and Algae Dynamics’ endeavors could hit some amazing numbers and exceed even that eye-popping growth rate.

For more information, visit the company’s website at www.AlgaeDynamics.com

Let us hear your thoughts: Algae Dynamics Corp. Message Board

From Our Blog

Longeveron Inc. (NASDAQ: LGVN) Discusses 2023 Progress and 2024 Plans in Corporate Update

March 28, 2024

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing regenerative medicine for life-threatening conditions with unmet medical needs, recently released its full-year results for the period ended December 31, 2023, and provided a corporate update (https://ibn.fm/iORBu). Results from multiple studies using Longeveron’s lead investigational therapeutic candidate, Lomecel-B(TM), were announced by the company last year. “In 2023 […]

Rotate your device 90° to view site.